• Mashup Score: 0
    Eyeworld - DEC 2020 - 3 year(s) ago

    EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

    Tweet Tweets with this article
    • Ongoing work being done in search of a pharmacological cataract solution ➡️ https://t.co/py2nW5UXSC #cataract #ophthalmology https://t.co/OlepYNaWq4

  • Mashup Score: 0
    Eyeworld - DEC 2020 - 3 year(s) ago

    EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

    Tweet Tweets with this article
    • The pandemic pushes innovation in the world of remote testing and diagnostics➡️ https://t.co/W8mtrHhYIq #ophthalmology https://t.co/N5wU1kiGTT

  • Mashup Score: 0
    Eyeworld - DEC 2020 - 3 year(s) ago

    EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

    Tweet Tweets with this article
    • The protocols in place to ensure safety of donor eye tissue during the #COVID-19 pandemic ➡️ https://t.co/Ut3cZJblk6 #cornea #eyebanking #ophthalmology https://t.co/Cv0C3oikgd

  • Mashup Score: 0
    EyeWorld | 2020-12-18 - 3 year(s) ago

    COVID-19 vaccine update Last week, the FDA issued emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine, the first to become available in the U.S. On Thursday the FDA’s Vaccines and Related Biological Products Advisory Committee recommended that the FDA authorize emergency use of the Moderna…

    Tweet Tweets with this article
    • News of the week: A COVID-19 vaccine update, a Phase 2b trial for blepharitis treatment, Phase 2 results for a drug using the melanocortin pathway for DED, and more. Read about it in EyeWorld Weekly: https://t.co/xHiss1GvRe https://t.co/15kMuzuOJV

  • Mashup Score: 0
    Eyeworld - DEC 2020 - 3 year(s) ago

    EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

    Tweet Tweets with this article
    • Survey reveals what IOL ophthalmologists would choose—and EyeWorld medical editors weigh in, too ➡️ https://t.co/4ghbs7Poov #cataract #cornea #ophthalmology https://t.co/wfRQ05Ui58

  • Mashup Score: 0
    EyeWorld | 2020-12-11 - 3 year(s) ago

    Two Phase 3 studies for dry eye therapies This week, two companies—Aldeyra Therapeutics and Novaliq—announced the enrollment of patients for their separate Phase 3 studies evaluating their respective therapies for dry eye disease. Aldeyra Therapeutics enrolled the first patient for its Phase 3 TRANQUILITY study,…

    Tweet Tweets with this article
    • News of the week: Phase 3 DED studies, separate payment for OMIDRIA, the latest in ASCRS initiatives, and more. Read about it in EyeWorld Weekly https://t.co/Z8KDR7NHr7 https://t.co/dUjOBtFHWC